Reticulocalbin 1 (RCN1), an endoplasmic reticulum (ER)-resident Ca 2+ -binding protein, is dysregulated in cancers, but its pathophysiological roles are largely unclear.
Ca
2+ ion, interacts with Sec63p, which is an ER protein translocase that guides the transport of newly synthesized proteins from the cytosol to the ER lumen. In addition, extracellular calumenin binds to and stabilizes fibulin-1, leading to inactivation of extracellular signal-regulated kinase 1 and 2 (ERK1/2)-mediated signaling and suppression of cell migration and tumor metastasis. 5, 6 Therefore, ER-associated proteins are not confined to the ER lumen or to the secretory pathway, and their physiological functions and roles in diseases continue to be investigated.
Reticulocalbin 1 (RCN1) is also a member of the CREC family.
RCN1 localizes to the ER and contains 6 EF-hand motifs and an ER-retention motif, HDEL, in the carboxyl-terminal sequence. RCN1
is a Ca 2+ -binding protein that is involved in the regulation of Ca 2+ -dependent activities in the ER lumen and is present throughout the whole secretory pathway of mammalian cells. 4, 7 Multiple studies have shown that RCN1 is heterogeneously expressed and necessary for cell bioactivity. 8 The differentially expressed RCN1 is correlated with diseases such as cancer. RCN1 overexpression has been observed in invasive breast cancer cells, 9 colorectal cancer cells, 10 thermoresistant gastric cancer cells, 11, 12 liver cancer cells 13 and prostate cancer (PCa) cells, 14 suggesting a role for RCN1 in tumorigenesis and invasion. 15, 16 However, the relevance of RCN1
protein levels in tumor malignancy is unclear. RCN1 is reportedly present in highly invasive breast cancer cell lines but not in poorly invasive lines. 9 However, RCN1 mRNA levels are not correlated with the metastatic pattern of PCa cells. 14 In addition, RCN1 is involved in regulating drug resistance, and downregulation of RCN1
is observed in cisplatin-resistant non-small cell lung cancer cells. 17 In contrast, high RCN1 levels potently drive the formation of doxorubicin resistance. 18 Thus, the definitive physiological and pathophysiological roles of RCN1 and fundamental mechanisms underlying RCN1 are poorly understood and have yet to be elucidated.
In this study, we aimed to establish the significance of RCN1 in PCa cell survival and proliferation. Our data revealed that RCN1 was overexpressed in clinical PCa tissue samples and that downregulation of RCN1 in PCa cells triggered ER stress, leading to cell apoptosis and necroptosis. were measured on a flow cytometer (Becton Dickinson, NJ, USA).
| MATERIALS AND METHODS

| Patient samples
The MMP levels were calculated as the red/green fluorescence ratio.
| Caspase-3 activity
The caspase-3 activity in cells was evaluated using the Caspase-3
Activity Assay Kit (Beyotime). The absorbance was measured at 405 nm, and the relative activity of caspase-3 was determined.
| Western blot
Whole cell lysates and western blotting were prepared as previously described. 19 The GRP78/BIP and cyclin B1 were purchased from Proteintech (China).
Bands on the immunoblots were visualized using an enhanced chemiluminescence detection system (Millipore, DT, Germany) and exposed to X-ray films. were assigned a mean score that considered both the intensity of the staining and the positive reactions.
| Statistical analysis
The differences in protein levels among the BPH and PCa tissues were analyzed using Fisher's exact test. Kaplan-Meier and Cox proportional hazards analyses were used for survival analysis. The data are presented as the mean AE SD of at least 3 independent experiments. The mean difference between the control and treated groups was determined using Student's t tests. Two-way ANOVA with
Bonferroni's post-test was used to compare all groups. A value of P < .05 was considered statistically significant.
| RESULTS
| Reticulocalbin 1 is highly expressed in prostate cancer
We initiated our study by examining RCN1 expression in human tissues from the Chinese Han population. Staining of the RCN1 protein in tumor tissues was strong (7/11), and RCN1 was detectable in the BPH samples (4/15) ( Figure 1A However, a survival analysis using online microarray data 21 revealed no significant association between the high RCN1 mRNA level and disease-free survival of PCa patients ( Figure 1F , HR = 1.13, P = .067),
suggesting that RCN1 might not be associated with PCa progression or the malignant phenotype, which is consistent the observation that RCN1 levels do not correlate with the metastatic pattern of PCa. 14 The basal RCN1 levels showed that RCN1 was lowest in the invasive PC-3 cells, moderate in RWPE1 cells, but predominantly found in LNCaP and DU145 cells ( Figure 1G ), which is consistent with a previous report. 14 We overexpressed RCN1 in PC3 cells and the results ( Figure 1H ) showed that ectopic expression of RCN1 had a limited effect on nuclear EdU incorporation and cell viability. In addition, RCN1 overexpression did not affect cyclin D1 and moderately increased cyclin B expression ( Figure 1I ). Similar results were observed in DU145 cells ( Figure 1J ) and bladder cancer 5637 cells after transfection of pcDNA3.1-RCN1. The result of 5637 is not shown. Our results were consistent with Ki67 index-based observations that RCN expression was not associated with the proliferative activities of cells that strongly expressed RCN1. 8 Thus, RCN1 is broadly expressed in BPH and PCa tissues and may have a role in maintaining cell survival rather than driving cell proliferation.
| Reticulocalbin 1 knockdown differentially induces apoptosis and necroptosis
To explore the role of RCN1, we performed cell cycle analysis.
Depletion of endogenous RCN1 caused an accumulation of DU145 cells in the S phase ( Figure 2A ). However, downregulation of RCN1
in LNCaP cells arrested the cell cycle at the G2/M-phase ( Figure 2B ).
In addition, RCN1 knockdown significantly suppressed cell viability for both DU145 ( Figure 2C ) and LNCaP cells ( Figure 2D ), which was accompanied with induction of apoptosis ( Figure 2E ,F).
As we noted that sub-G1 was shown in RCN1-reduced DU145 cells (Figure 2A LNCaP cells ( Figure 2G ). These data confirm that RCN1 knockdown leads to PCa cell death.
We subsequently investigated whether RCN1 depletion-induced cell death was associated with caspase activation, which is a typical apoptosis pathway. RCN1 depletion in DU145 cells led to the activation of caspase-3, whereas no significant change was observed in LNCaP cells ( Figure 3A ). Cleavage of the nuclear enzyme PARP, which is a hallmark of apoptosis, became noticeably higher in RCN1-depleted DU145 cells in a time-dependent manner. Increase in the PARP cleavage was also obvious in bladder cancer and colon cancer cells ( Figure S1 ). However, cleaved PARP remained almost unchanged in the LNCaP cells ( Figure 3B ). Z-VAD, a pan-caspase inhibitor, partially rescued RCN1 depletion-induced cell death in DU145 cells ( Figure 3C ) but did not rescue LNCaP cells (Figure 3D ), supporting the observation that RCN1 knockdown mainly triggered apoptosis in DU145 cells (Figure 2 ). We also used necrostatin-1, an inhibitor of necroptosis, to determine whether necroptosis was involved in RCN1 depletion-induced cell death. Necrostatin-1 clearly reversed the cell death in siRCN1-treated LNCaP cells, suggesting that necroptosis, at least partially, contributed to siRCN1-mediated LNCaP cell death ( Figure 3E,F) . Thus, RCN1 knockdown differentially
is highly expressed in prostate tissues. A, Immunohistochemistry was used to determine RCN1, cyclin D1 and cyclin B.
The statistical analysis of (B) RCN1, (C) cyclin D1 and (D) cyclin B were shown. *P < .05, **P < .01, n.s., no significance. E, Expression of RCN1 in prostate carcinoma was analyzed using the datasets from the Oncomine database. F, Survival analysis was shown using online microarray data with survival information between the high level of RCN1 mRNA with disease-free survival in PCa patients (HR = 1.13, P = .067). G, The protein levels of RCN1 in RWPE1, PC3, DU145 and LNCaP were detected. H, Proliferation of PC3 cells transfected with pcDNA3.1-RCN1 for 72 hours was detected using EdU. The charts indicate the number of EdU-positive cells. I, PC3 and (J) DU145 were transfected with pcDNA3.1-RCN1 for 72 hours. MTT assay and western blotting were performed. n.s., no significance F I G U R E 2 Reticulocalbin 1 (RCN1) depletion induces cell cycle arrest and cell death. A, DU145 and (B) LNCaP cells were transfected with siRCN1 for 48 or 72 hours. Cell cycle analyses were performed by flow cytometry, *P < .05. C, DU145 and (D) LNCaP cells were transfected with siRCN1 for 72 hours. Cell viability, morphological images and western blotting were obtained. **P < .01, ***P < .001. E, DU145 and (F) LNCaP cells were transfected with siRCN1 for 48 or 72 hours and stained with FITC-conjugated annexin V and propidium iodide for flow cytometry. Statistical analysis is shown. *P < .05, **P < .01, ***P < .001, n.s., no significance. G, Changes of mitochondrial membrane potential (mtDw) were shown after RCN1 deletion in DU145 and LNCaP; *P < .05, ***P < .001 triggered cell cycle arrest at the S phase or G2/M phase and promoted caspase-dependent apoptosis and necroptosis in PCa cells.
| Reticulocalbin 1 depletion activates endoplasmic reticulum stress and CaMKII
Because the ER-resident RCN1 protein is a Ca 2+ -binding protein, we hypothesized that RCN1 depletion triggers ER stress, which, in turn, promotes cell death. The results ( Figure 4A ) showed that the expression of glucose-related protein 78 (GRP78), a sensor of the ER stress response, was elevated in RCN1-depleted DU145 and LNCaP cells.
Increases in the phosphorylation of PRKR-like endoplasmic reticulum kinase (PERK) and its substrate, eIF2a, were evident at 24 hours, and became moderate or weak after longer siRCN1 transfection. In addition, C/EBP-homologous protein CHOP, an indicator of ER stress-associated apoptosis, was barely detectable in RCN1-deficient LNCaP cells. However, induction of CHOP was initiated at 24 hours, and became stronger after prolonged depletion of RCN1 in DU145 cells ( Figure 4A ), reinforcing the observations that DU145 cells was prone to apoptosis when cells lose RCN1 (Figures 2 and 3) . We included sodium 4-phenylbutyrate (4-PBA) and GSK2606414, 2 specific PERK inhibitors, which attenuate the ER stress, 23 to confirm the role of ER stress in RCN1 depletion-induced cell death. Pretreatment with either 4-PBA or GSK2606414 alleviated the ER stress, and increased both DU145 and LNCaP cell survival when RCN1 was reduced ( Figure 4B -E).
We examined whether loss of RCN1 rendered cells unable to 
| Reticulocalbin 1 ablation modulates phosphatase and tensin homolog activity
We next examined the involvement of AKT pathway due to the critical role in cell survival and proliferation. 27, 28 Loss of RCN1 resulted Cell viability and western blotting were obtained. *P < .05. **P < .01. C, DU145 and (E) LNCaP cells were pre-treated with GSK2606414 (10 lmol/L) for 5 hours and transfected with NC or siRCN1 for 48 hours. Cell viability and western blotting was performed. **P < .01, ***P < .001. F, DU145 and LNCaP cells were transfected with siRCN1. Then, cells were collected for western blot analysis. G, DU145 or (H) LNCaP cells were transfected with NC or siRCN1 for 24 hours and subsequently exposed to xestospongin C (5 lmol/L) or ryanodine (1 lmol/L) for 24 hours. Cell viability was monitored by using MTT assays. *P < .05, **P < .01 LIU ET AL. 
Given the importance of androgen receptor (AR) signaling on
LNCaP cell proliferation, we explored the involvement of AR in RCN1 deficiency-mediated cell death. The results revealed that RCN1 silencing did not affect AR expression in LNCaP cells (Figure 5F ). In addition, AR knockdown had a limited effect on RCN1 expression ( Figure 5G ), suggesting that the AR might not play a critical role in RCN1 depletion-mediated cell death. H, Western blotting was performed and quantified by Image J software. *P < .05, **P < .01, ***P < .001 cell apoptosis in a caspase-dependent manner but caused necropto- Several studies have demonstrated that downregulation of RCN1 in some cancer cells significantly suppresses cell proliferation. 32, 34 Our findings reinforce these observations that RCN1 deletion significantly suppresses PCa cell viability. Knockdown of RCN1 causes PTEN activated in DU145 cells, leading to inactivation of AKT and cellular apoptosis. Thus, upregulation of PTEN contributes to the switch from cell survival to cell apoptosis upon RCN depletion. Further investigations are required to explore the regulatory mechanisms by which RCN1 negatively modulates PTEN expression and activity.
As an ER-resident Ca 2+ -binding protein, RCN1 downregulation induced ER stress, which was associated with CaMKII activation.
Inhibition of IP3R, instead of RyR, partially restored RCN1 depletioninduced cell death. Therefore, CaMKII activation might be a consequence of interrupted IP3R signaling upon RCN1 depletion. This notion is supported by a recent study showing that RCN1 specifically interacts with IP3R1 and inhibits Ca 2+ release from the ER, thereby suppressing ER stress-induced apoptosis. 34 CaMKII overexpression or activation is believed to promote cancer cell proliferation and serves as a target for chemotherapy. 35, 36 However, CaMKIIdependent apoptosis has also been observed in multiple cultured cell lines. 37 Recently, Nomura et al 38 provided evidence that increased cytoplasmic Ca 2+ triggers necroptosis by activating CaMKII/RIP1.
We also found that CaMKII activation was sustained up to 72 hours in RCN1-deficient LNCaP cells and may be responsible for a process involved in necroptosis. CaMKII-independent mechanisms may also contribute to the induction of cell death in response to RCN1 depletion. In summary, RCN1 depletion promotes PCa cell apoptosis and necroptosis, at least in part, through CaMKII activation and AKT suppression, suggesting a role for RCN1 in maintaining cancer cell survival and its potential usefulness in cancer therapy.
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